MedPath

Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)

Active, not recruiting
Conditions
Primary Biliary Cirrhosis
Registration Number
NCT01161953
Lead Sponsor
Mayo Clinic
Brief Summary

Primary Biliary Cirrhosis (PBC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC.

This study is being done to investigate whether genes make people more likely to develop PBC. Discovery of these proposed genes will help us better understand how PBC developes, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • Men and women between the ages of 18-90 who have a history of PBC.
  • PBC patients who have undergone a liver transplant are eligible.
  • Family members (1st degree relatives) of enrolled PBC patients are eligible.
Read More
Exclusion Criteria
  • Individuals with no history of PBC or those unable to provide consent.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mapping of Susceptibility Genes in Adult Chronic Cholestatic Liver Diseases

Adult chronic cholestatic liver diseases, such as Primary Biliary Cirrhosis (PBC), are progressive liver disorders of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC.

This study is being done to investigate whether genes (the inherited genetic material passed from parents to their children) make people more likely to develop PBC. Discovery of these proposed genes will help us to better understand how PBC progresses, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath